NICE rapped for drug restrictions3rd August 2006
The National Institute for Health and Clinical Excellence (NICE) is under fire over its decisions to restrict a range of drugs used to treat Alzheimer’s disease.
NICE heard five appeals over two days from campaign groups and drug companies over limiting medicines for treating moderate stages of the condition.
The drugs include donepezil, rivastigmine, and galantamine, and memantine, which is not recommended for use outside clinical trials.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: NICE rapped for drug restrictions
Author: Chris May
Article Id: 600
Date Added: 3rd Aug 2006